Nuveen Asset Management, LLC Provention Bio, Inc. Transaction History

Nuveen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$6.7 - $24.21 $496,744 - $1.79 Million	-74,141 Reduced 18.03%	337,165 $8.13 Million
Q4 2022 Feb 14, 2023	BUY	$4.52 - $10.57 $132,928 - $310,853	29,409 Added 7.7%	411,306 $4.35 Million
Q3 2022 Nov 14, 2022	SELL	$3.43 - $5.62 $2,534 - $4,153	-739 Reduced 0.19%	381,897 $1.72 Million
Q2 2022 Aug 15, 2022	SELL	$3.65 - $7.3 $229,606 - $459,213	-62,906 Reduced 14.12%	382,636 $1.53 Million
Q1 2022 May 16, 2022	SELL	$3.4 - $7.88 $1,421 - $3,293	-418 Reduced 0.09%	445,542 $3.29 Million
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $46,592 - $61,595	8,335 Added 1.9%	445,960 $2.51 Million
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $1.19 Million - $1.75 Million	209,786 Added 92.08%	437,625 $2.92 Million
Q2 2021 Aug 16, 2021	SELL	$6.71 - $11.04 $785,251 - $1.29 Million	-117,027 Reduced 33.93%	227,839 $1.92 Million
Q1 2021 May 17, 2021	BUY	$10.12 - $19.45 $31,746 - $61,014	3,137 Added 0.92%	344,866 $3.62 Million
Q4 2020 Feb 16, 2021	SELL	$11.79 - $18.94 $384,000 - $616,875	-32,570 Reduced 8.7%	341,729 $5.79 Million
Q3 2020 Nov 16, 2020	BUY	$10.34 - $15.2 $2.15 Million - $3.16 Million	207,787 Added 124.79%	374,299 $4.8 Million
Q2 2020 Aug 14, 2020	BUY	$7.81 - $17.0 $1.3 Million - $2.83 Million	166,512 New	166,512 $2.35 Million

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.